Our results uncover several novel VDR-target genes in human hepatocytes that coordinate an important perturbation in glycerolipid and phospholipid levels, which could have clinical relevance in prevalent diseases such as NAFLD. The gene discussed is VDR; the disease is metabolic dysfunction-associated steatotic liver disease.